In this line, Ma et al. indicated that the NK-1R antagonist, L-733,060, inhibited SP-induced expression of VEGF-C and MMP-9 in endometrial adenocarcinoma cells, thus reducing tumor invasion and metastasis [32]. Here, MMP9 is linked to endometrium adenocarcinoma.